ENTRY       D12494            Mixture   Drug
NAME        Foslevodopa and foscarbidopa;
            Vyalev (TN)
COMPONENT   Foslevodopa [DR:D11839], (Foscarbidopa hydarate [DR:D11879] | Foscarbidopa [DR:D12057])
CLASS       Metabolizing enzyme substrate
             DG01592  COMT substrate
            Unclassified
             DG03250  DDC substrate
REMARK      Therapeutic category: 1169
            ATC code: N04BA07
            Product: D12494<JP>
EFFICACY    Antiparkinsonian
METABOLISM  Enzyme: COMT [HSA:1312], DDC [HSA:1644]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BA Dopa and dopa derivatives
                 N04BA07 Foslevodopa and decarboxylase inhibitor
                  D12494  Foslevodopa and foscarbidopa &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D12494  Foslevodopa and foscarbidopa
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01592  COMT substrate
               D12494  Foslevodopa and foscarbidopa
             Unclassified
              DG03250  DDC substrate
               D12494  Foslevodopa and foscarbidopa
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D12494
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12494
///
